| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |